Valeant Pharmaceuticals

Contact
valeant.com
+19494616000

Valeant Pharmaceuticals International

One Enterprise
92656 Aliso Viejo
USA
+19494616000
valeant.com
Contact
Profile News
Contact

About Valeant Pharmaceuticals

Valeant Pharmaceuticals International is a global specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, infectious disease and dermatology.

Read more about Valeant Pharmaceuticals
Facts about Valeant Pharmaceuticals
  • Focus : Manufacturer
  • Industry : Pharma

News about Valeant Pharmaceuticals

Valeant Pharmaceuticals

08-Feb-2012 | business & finance

Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan

Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a ...

Read news
Valeant Pharmaceuticals

06-Feb-2012 | business & finance

Valeant Pharmaceuticals Acquires Probiotica in Brazil

Valeant Pharmaceuticals International, Inc. announced that Valeant has acquired Probiotica Laboratorios Ltda. Probiotica currently markets a full line of ...

Read news
Valeant Pharmaceuticals

22-Nov-2011 | business & finance

Valeant Pharmaceuticals Agrees to Acquire iNova

Valeant Pharmaceuticals International, Inc. announced that it has signed an agreement to acquire iNova, a private pharmaceutical group which sells and ...

Read news
Valeant Pharmaceuticals

25-Oct-2010 | business & finance

Santhera Regains Full Rights to Fipamezole in North America

Santhera Pharmaceuticals announced that as of January 2011 it regains the US and Canadian rights for fipamezole from Biovail Laboratories International, ...

Read news
Valeant Pharmaceuticals

16-Sep-2008 | business & finance

Valeant Pharmaceuticals Completes Sale of Certain European Operations to Meda AB

Valeant Pharmaceuticals International announced that it has completed its sale of certain business operations located in Western Europe, Eastern Europe, ...

Read news
Valeant Pharmaceuticals

01-Sep-2008 | business & finance

Valeant Pharmaceuticals and GlaxoSmithKline Announce Worldwide Collaboration Agreement for Retigabine

GSK to make upfront payment to Valeant of $125 million

Read news
Show more news about Valeant Pharmaceuticals

Here you will find Valeant Pharmaceuticals International